For more than two decades, Eli Casdin has been focused on researching and investing in the Life Science Industry. His 2011 black book, “The Dawn of Molecular Medicine,”presaged the emerging molecular medicinerevolution that is now reshaping every aspect of the healthcare and industrial sectors. He founded Casdin Capital that same year, investing in and partnering with industry leaders. His deep and broad engagement involves the firm in everything from testing and targeted medicines to diagnostics and synthetic biology.